The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach.

ABSTRACT:

Introduction

The term progressive fibrosing interstitial lung disease (ILD) describes patients with fibrotic ILDs who, irrespective of the aetiology of the disease, show a progressive course of their disease despite current available (and non-licensed) treatment. Besides in idiopathic pulmonary fibrosis, little is known about management and the burden of patients with fibrotic ILD, particularly those with a progressive behaviour.

Methods

Using the Delphi method, 40 European experts in ILD management delivered information on management of (progressive) fibrosing ILD and on the impact of the disease on patients' quality of life (QoL) and healthcare resource utilisation (HCRU). Annual costs were calculated for progressive and non-/slow-progressive fibrosing ILD for diagnosis, f

SUBMITTER: Wuyts WA 

PROVIDER: S-EPMC7467418 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature